Kyowa Medex to Take over Sales of Astellas Pharma's In Vitro Diagnostic Product UROPIECE S.Tokyo, Japan, Aug 10, 2005 - (JCNN JCNN Japan Corporate News Network ) - Kyowa Medex has agreed with Astellas Pharma on the upcoming transfer of UROPIECE S, Astellas Pharma's in vitro in vitro /in vi·tro/ (in ve´tro) [L.] within a glass; observable in a test tube; in an artificial environment. in vi·tro adj. In an artificial environment outside a living organism. diagnostic product. As of October 1, Kyowa Medex will receive the distribution right of UROPIECE S from Astellas Pharma. UROPIECE S, Astellas Pharma's proprietary urine test paper, can simultaneously measure up to nine items, including urinary urobilinogen, protein and occult blood occult blood n. Blood that is present in amounts too small to be seen and can be detected only by chemical analysis or microscopic examination. Occult blood Presence of blood that cannot be seen with the naked eye. , in 30 seconds. It is widely used in medical practices and group examinations conducted by medical institutions. With this move, Kyowa Medex aims to consolidate its foothold in the Point of Care market in Japan. Source: JCN JCN Japan Corporate News JCN Journal of Cognitive Neuroscience JCN Journal of Cardiovascular Nursing JCN Journal of Christian Nursing JCN Job Control Number JCN Journal of Child Neurology JCN joint communications network (US DoD) http://www.japancorp.net Copyright [c] 2005 Japan Corporate News Network. All rights reserved. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion